By Robert Roos, News Editor Mar 21, 2011 (CIDRAP News) – Preliminary studies suggest that this year’s trivalent seasonal flu vaccine used in Europe was less effective against the 2009 H1N1 virus than last year’s monovalent H1N1 vaccine was, possibly because of some degree of mutation in the virus, according to recent reports in Eurosurveillance. […]
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance From the Advisory Committee on Immunization Practices (ACIP)
MMWR. 2010;59:630-632 On October 16, 2009, the Food and Drug Administration licensed quadrivalent human papillomavirus vaccine (HPV4; Gardasil, Merck & Co. Inc.) for use in males aged 9 through 26 years for prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. HPV4 had been licensed previously for use in females aged […]
Research and Markets: Women's Health Review and Outlook 2011
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Women’s Health Review and Outlook 2011” report to their offering. The global women’s health market, valued at $20 billion in 2009, is dominated by the United States. Hormonal contraceptives is one of the leading categories within the market. Bayer’s Yaz, Yasmin, and Yasminelle were the […]
Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines
Psyrri A, Boutati E, Karageorgopoulou S; Anti-Cancer Drugs (Mar 2011) Human papillomaviruses (HPVs), especially type 16, are implicated in the development of a subset of head and neck squamous cell cancers (HNSCCs). This subset of oropharyngeal cancers possesses distinct clinical and laboratory features and outcome, and is particularly common in individuals who lack the traditional […]
To improve drug safety, FDA should check its mixed-up files
Boston.com March 20, 2011 FOLLOWING A number of high-profile drug safety scandals in recent years — such as Vioxx and Avandia — the pharmaceutical industry and the Food and Drug Administration are spending a great deal of energy trying to uncover, as early as possible, rare side effects that make a drug too risky. Sometimes, […]
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 199
- Next Page »